To evaluate the response of PCa to WCE treatment, we first measured the cell cycle distribution following WCE treatment in three different PCa cell lines: AR-positive, androgen-dependent LNCaP, AR-positive but castration-resistant 22Rv1, and AR-negative, hormone-refractory PC-3. The gene discussed is AR; the disease is posterior cortical atrophy.